Holen Sie sich die Stockscreener-App
2.91
1.04%
0.03
Handel nachbörslich:
2.91
Schlusskurs vom Vortag:
$2.88
Offen:
$2.92
24-Stunden-Volumen:
88,050
Relative Volume:
0.40
Marktkapitalisierung:
$114.62M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-1.7425
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
+0.00%
1M Leistung:
-1.02%
6M Leistung:
-33.10%
1J Leistung:
-55.98%
1-Tages-Spanne:
$2.84
$3.01
1-Wochen-Bereich:
$2.84
$3.0994
52-Wochen-Spanne:
$2.30
$7.84
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
2.91 | 114.62M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November - MarketBeat
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
TELA Bio Reports Third Quarter 2024 Financial Results - The Manila Times
What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings - GuruFocus.com
TELA Bio Announces Inducement Grants of Restricted Stock Units to New Employees - MSN
TELA Bio (TELA) to Release Quarterly Earnings on Thursday - MarketBeat
Tela Bio Commercially Launches OviTex IHR in the US - MPO-mag
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tela Bio Inc-Aktie (TELA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):